Dynamic tailoring of treatment durations improves efficiency of hepatitis C treatment with pegylated interferon and ribavirin

Summary The treatment durations for hepatitis C are guided by the analysis of hepatitis C virus (HCV) RNA in blood at certain time points. This multicentre, randomized open label trial evaluated the utility and performance of individualized treatment durations guided by viral decline rates in 103 pa...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of viral hepatitis 2013-04, Vol.20 (4), p.e82-e89
Hauptverfasser:	Lindh, M., Arnholm, B., Björkman, P., Hellstrand, K., Lagging, M., Nilsson, S., Wahlberg, T., Wallmark, E., Weiland, O., Wejstål, R., Westin, J., Widell, A., Norkrans, G.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antiviral Agents - administration & dosage Clinical Medicine Drug Therapy, Combination - methods early viral kinetics Female Gastroenterologi Gastroenterology and Hepatology genotype-1 HCV Hepacivirus - isolation & purification Hepatitis C virus Hepatitis C, Chronic - drug therapy Humans infection Infectious Medicine Infektionsmedicin interferon Interferon-alpha - administration & dosage kinetics Klinisk medicin Male Medical and Health Sciences Medicin och hälsovetenskap Middle Aged peginterferon plus ribavirin Polyethylene Glycols - administration & dosage Recombinant Proteins - administration & dosage ribavirin Ribavirin - administration & dosage RNA, Viral - blood therapy Time Factors Treatment Outcome Viral Load virus Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!